Centrus Energy Corp. (LEU)
NYSEEnergyUraniumSnapshot 2026-09-04
$173.89+2.01%
Close 2026-09-04 · 1-day change
NYSEEnergyUraniumSnapshot 2026-09-04
Intact: The reason to own it still holds.
Centrus is growing revenue with a $450M to $500M target in 2026. It is expanding its uranium enrichment plant in Ohio. The company signed positive contracts with the U.S. Department of Energy. These moves support future growth.
Revenue fell sharply in early 2026 despite guidance increases. Profit margins are fragile and valuation is high. The stock is down 28.5% from its high, showing market doubts.
The market expects about 7% revenue growth next year. Our fair value is near $97, slightly above the current price. The stock price reflects cautious optimism but also risks.
Breaks if: Capital spending falls below $350M in FY26
Maintain capital deployment guidance in the range of $350 million to $500 million to support industrial build-out and centrifuge manufacturing expansion.
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
LEU represents a speculative growth investment with a focus on expanding its uranium enrichment capabilities. The current thesis state reflects a cautious outlook due to mixed management performance and high valuation compared to peers.
The market appears to be pricing in a high level of fragility due to expensive valuation and weak execution quality. There is an expectations gap, indicating that investors may be anticipating better performance than what has been recently delivered.
Fundamentals may show modest growth as management has raised revenue guidance for 2026 and is focused on capital deployment. However, the recent financial performance has been neutral, and there is a risk of earnings misses given the erratic nature of recent earnings surprises.
The thesis hinges on several factors, including inflation trends that could benefit LEU and the performance of sector peers like UEC. Additionally, any potential cuts to guidance could negatively impact sentiment and expectations.
The most important moves since the prior daily snapshot.
Yes, our read has strengthened. The latest earnings beat supports a more favorable outlook. Additionally, the expansion of the uranium enrichment facility at Piketon and Oak Ridge reinforces growth potential. There are no new threats impacting the thesis at this time.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Stated as a priority in 3 disclosures including 2026-Q1 and 2026-Q2. The company consistently guided capital deployment in the range of $350 million to $500 million for 2026 to support its industrial build-out and centrifuge manufacturing expansion. This guidance has remained stable, indicating management's continued focus on disciplined capital allocation.
“Total capital deployment to be in the range of $350 million to $500 million.”
“Total capital deployment to be in the range of $350 million to $500 million.”
Breaks if: Expansion progress stalls or reverses in next 12 months
Centrus is expanding its uranium enrichment facility in Piketon, Ohio, as part of a multi-billion dollar project.
Breaks if: Revenue falls below $450M in FY26
In the next 1 to 3 years, LEU's performance will depend on management's ability to execute on its priorities and external economic factors. Not investment advice.